trending Market Intelligence /marketintelligence/en/news-insights/trending/krm1lzumplqtzgtu1o6n7q2 content esgSubNav
In This List

Marinus adds former Pacira Pharmaceuticals COO to board

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Marinus adds former Pacira Pharmaceuticals COO to board

Marinus Pharmaceuticals Inc. appointed Scott Braunstein to its board.

Braunstein currently serves as an operating partner at Aisling Capital Management LP, a New York-based venture capital and private equity firm.

Prior to joining Aisling, Braunstein was the COO of Pacira Pharmaceuticals Inc., a Parsippany, N.J.-based specialty pharmaceutical company that develops and manufactures products for acute care practitioners and their patients.

Radnor, Pa.-based Marinus Pharmaceuticals is focused on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders.